Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;21(6):1392-400.
doi: 10.1097/MIB.0000000000000391.

Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease

Alyssa Parian  1 , Christina Y Ha
Affiliations

Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease

Alyssa Parian et al. Inflamm Bowel Dis. 2015 Jun.

Abstract

Background: Comorbidity and polypharmacy, more prevalent among older persons, may impact the treatment of patients with inflammatory bowel disease (IBD). The aims of this study were to assess the frequency of polypharmacy and medication interactions within a cohort of older patients with IBD and describe IBD treatment patterns.

Methods: Cohort study of 190 patients with IBD 65 years or older followed at a tertiary IBD referral center from 2006 to 2012. Data collected included demographics, IBD-specific characteristics including disease activity, and comorbidity. Medication histories were extracted from medical records, and data were used to classify polypharmacy, frequency, and severity of potential medication interactions and inappropriate medication use.

Results: Older patients with IBD were prescribed an average of 9 routine medications. Severe polypharmacy (≥10 routine medications) was present in 43.2% of studied patients and associated with increasing age, greater comorbidity, and steroid use. Overall, 73.7% of patients had at least 1 potential medication interaction, including 40% of patients with potential IBD medication-associated interactions. Chronic steroids were prescribed to 40% of the older patients including 24% who were in remission or with mild disease activity. Only 39.5% of patients were on immunomodulators and 21.1% on biologics. Approximately, 35% of patients were given at least 1 Beers inappropriate medication and almost 10% were receiving chronic narcotics.

Conclusions: Older patients with IBD are at increased risk for severe polypharmacy and potential major medication interactions especially with increasing comorbidity and chronic steroid use. Steroid-maintenance therapies are prevalent among the older patients with IBD with lower utilization of steroid-sparing regimens.

PubMed Disclaimer

Conflict of interest statement

C. Y. Ha: AbbVie Scientific Advisory Board. A. Parian has no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Medication utilization among older patients with IBD stratified by disease type and activity.
FIGURE 2
FIGURE 2
A, Frequency and severity of potential medication interactions among older patients with IBD. B, Frequency of potential medication interactions stratified by IBD medication class.
See this image and copyright information in PMC

References

    1. 2010 Census Data on Aging. Available at: http://www.aoa.gov/aoaroot/aging_statistics/Census_Population/census2010.... Accessed December 5, 2011.
    1. Catlin A, Cowan C, Hartman M, et al. National health spending in 2006: a year of change for prescription drugs. Health Aff (Millwood). 2008;27:14–29. - PubMed
    1. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–1116. - PubMed
    1. Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161:1629–1634. - PubMed
    1. Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867–2878. - PMC - PubMed